Saturday 17 October 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024. In the quarter to June 2026, revenue grew 24.1%, EPS grew 39.1% and free cash flow grew 40.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

316.58 13.42 −4.07%

Follow KRYS

Alert me

Market cap: $9.8B
P/E: 38.3×
Fwd P/E: 38.6×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	6	—	—	—	+8 more TTM periods Free account
ROE Full definition →	20.12%	19.90%	18.91%	19.66%
ROA Full definition →	18.30%	18.21%	17.14%	17.90%
ROIC Full definition →	24.07%	24.64%	25.73%	24.34%
Return on Tangible Assets Full definition →	22.23%	21.12%	19.10%	20.23%
Average Days of Receivables Full definition →	114.90	111.10	119.52	126.80
Free Cash Flow per Share Full definition →	8.73	8.11	6.54	5.73
Free Cash Flow Full definition →	257.78	237.38	189.35	166.02
Capital Expenditures Full definition →	(14.56)	(12.89)	(11.52)	(10.18)
Other line items
Cash ROIC Full definition →	11.69%	11.30%	9.25%	8.88%
Accounts Receivable Turnover Full definition →	3.52	3.62	3.35	3.29
Accounts Payable Turnover Full definition →	3.46	7.20	5.61	5.58
Inventory Turnover Full definition →	0.62	0.67	0.69	0.76
Average Days of Payables Full definition →	101.14	61.31	51.28	35.76
Days of Inventory on Hand Full definition →	704.10	639.41	640.96	641.70
Tax Rate Full definition →	0.07	0.09	0.08	0.06
Research and Development Expense of Revenue Full definition →	13.45%	14.17%	14.92%	15.22%
Selling, General and Administrative Expense of Revenue Full definition →	36.30%	37.17%	37.71%	36.60%
Share Based Compensation of Revenue Full definition →	12.41%	13.09%	14.01%	14.50%
Operating CF/Net income Full definition →	1.13	1.11	0.98	0.89
Depreciation/Fixed assets Full definition →	0.04	0.04	0.04	0.04
Capex/Depreciation Full definition →	(2.18)	(1.94)	(1.76)	(1.60)
Revenue per Share Full definition →	14.92	14.25	13.44	12.89
Operating CF per Share Full definition →	9.22	8.55	6.94	6.09
Capex per Share Full definition →	(0.49)	(0.44)	(0.40)	(0.35)
Capex to Sales Full definition →	0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly